ストックスクリーナーアプリを入手
0.2748
6.06%
0.0157
アフターアワーズ：
.27
-0.0048
-1.75%
前日終値:
$0.2591
開ける：
$0.253
24時間の取引高:
143.90K
Relative Volume:
0.02
時価総額：
$12.23M
収益：
$3.50M
当期純損益:
$-37.33M
株価収益率:
-0.2748
EPS:
-1
ネットキャッシュフロー:
$-19.15M
1週間 パフォーマンス:
-21.06%
1か月 パフォーマンス:
-36.61%
6か月 パフォーマンス:
-55.68%
1年 パフォーマンス:
-76.10%
1日の値動き範囲:
$0.253
$0.2791
1週間の範囲:
$0.2103
$0.36
52週間の値動き範囲:
$0.2103
$2.52
Hcw Biologics Inc Stock (HCWB) Company Profile
HCWB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
0.2748 | 12.23M | 3.50M | -37.33M | -19.15M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Hcw Biologics Inc (HCWB) 最新ニュース
HCWB stock touches 52-week low at $0.25 amid market challenges - MSN
HCW Biologics (NASDAQ:HCWB) Shares Down 20% – Here’s Why - Defense World
HCW Biologics Insiders Placed Bullish Bets Worth US$2.50m - Yahoo Finance
HCW Biologics (HCWB) Stock Price, News & Analysis - MarketBeat
HCW Biologics’ Founder and CEO to Address Opportunities and - GlobeNewswire
HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 - The Manila Times
HCW Biologics CEO to Share Breakthrough Immunotherapy Insights at 2025 GenScript Forum - StockTitan
HCW Biologics : January 2025. - Marketscreener.com
HCW Biologics (NASDAQ:HCWB) Stock Price Up 1.2% – Here’s What Happened - Defense World
HCW Announces Written Notice From NASDAQ - MENAFN.COM
HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq - Marketscreener.com
HCW Announces Written Notice from NASDAQ - Baystreet.ca
HCW Biologics Inc. Received NASDAQ Staff Determination Letter - GlobeNewswire
HCW Biologics Faces Nasdaq Delisting Threat After Market Value Falls Below $50M Requirement - StockTitan
HCW Biologics issues 2.55 million shares to Armistice Capital By Investing.com - Investing.com Nigeria
HCW Biologics issues 2.55 million shares to Armistice Capital - Investing.com India
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
HCW Biologics takes aim at CD8+ in deal with WY Biotech - The Pharma Letter
HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement - MSN
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.13% - MSN
HCW Biologics : Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules Form 8 K - Marketscreener.com
HCW Biologics Expands with New Financial Agreements - TipRanks
HCW Biologics prices $6.9M registered direct offering at $1.03 per share - Yahoo Finance
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLMA Must-Watch This Week! - Marketscreener.com
HCWB stock touches 52-week high at $1.97 amid robust gains - Investing.com Australia
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Yahoo Finance
HCW Biologics Secures $6.9M Above-Market Offering with Warrant Coverage | HCWB Stock News - StockTitan
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Benzinga
HCW Biologics Announces Pricing of $6.9 Million Registered - GlobeNewswire
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge - BP Journal
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase Program Boosts Investor Confidence - BP Journal
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement Sends Stock Up Over 310% - BP Journal
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.13% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13% - Investing.com
U.S. STOCKS Henry Schein Inc, Palantir Technologies, Uber Technologies - XM
Owning 44% shares,institutional owners seem interested in Jamieson Wellness Inc. (TSE:JWEL), - Yahoo Finance
HCW Biologics signs licensing deal with WY Biotech - Investing.com India
Trinity Investors Managing Partner Sanjay Chandra Named One of Dallas Most Influential Leaders on DCEO’s Dallas 500 List - Yahoo Finance
HCW Biologics Shares Surge on License Agreement - MarketWatch
Broward pharma developer inks $7 million deal with Chinese firm - The Business Journals
Enphase Energy Powers Up with US-Made IQ Batteries: Unlocking Bonus Tax Credits - AOL
California logistics company files for Chapter 11 - Yahoo Finance
Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November - Benzinga
Spirit Airlines Declares Bankruptcy After Failed Merger and Rising Costs - Yahoo Finance
Stock Market News: HCW Biologics increase by 521.18% while CareMax drops by 49.20% during mid day trading - Business Upturn
Ultra low-cost carrier Spirit Airlines files for bankruptcy - Yahoo Finance
U.S. STOCKS Tesla Inc, Palantir Technologies and Super Micro Computer Inc - XM
Nvidia Stock Drops on Report of Snag With Blackwell Chip Servers - Yahoo Finance
Why Is Penny Stock HCW Biologics Surging On Monday? - Yahoo Finance
Dow Falls 100 Points; Brady Posts Upbeat Results - Benzinga
Hcw Biologics Inc (HCWB) 財務データ
収益
当期純利益
現金流量
EPS
5.49%
0.79%
大文字化:
|
ボリューム (24 時間):